Kronos Bio Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
KRON is expected to report earnings to rise 114.29% to -30 cents per share on August 07
Q2'25
Est.
$-0.30
Q1'25
Beat
by $0.16
Q4'24
Missed
by $0.17
Q3'24
Beat
by $0.05
Q2'24
Beat
by $0.09
The last earnings report on May 30 showed earnings per share of -14 cents, beating the estimate of -30 cents. With 53.53K shares outstanding, the current market capitalization sits at 53.65M.